Meridian Wealth Management LLC Sells 157 Shares of The Clorox Company (NYSE:CLX)

Meridian Wealth Management LLC cut its stake in The Clorox Company (NYSE:CLXFree Report) by 5.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,488 shares of the company’s stock after selling 157 shares during the quarter. Meridian Wealth Management LLC’s holdings in Clorox were worth $404,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Brooklyn Investment Group grew its position in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the period. Prospera Private Wealth LLC bought a new stake in Clorox during the third quarter valued at approximately $27,000. Continuum Advisory LLC grew its position in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares during the period. Asset Planning Inc bought a new stake in Clorox during the fourth quarter valued at approximately $32,000. Finally, Halbert Hargrove Global Advisors LLC bought a new stake in Clorox during the fourth quarter valued at approximately $36,000. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently issued reports on CLX shares. Barclays boosted their target price on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. JPMorgan Chase & Co. upped their price target on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price target on shares of Clorox in a research report on Thursday, January 30th. Evercore ISI upped their price target on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and upped their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Clorox presently has an average rating of “Hold” and a consensus target price of $159.62.

View Our Latest Stock Analysis on Clorox

Clorox Price Performance

Clorox stock opened at $149.76 on Thursday. The company has a market cap of $18.45 billion, a price-to-earnings ratio of 40.92, a PEG ratio of 2.62 and a beta of 0.42. The firm’s fifty day moving average is $156.21 and its 200 day moving average is $160.41. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the business earned $2.16 EPS. Sell-side analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.26%. The ex-dividend date is Wednesday, April 23rd. Clorox’s payout ratio is 133.33%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.